Please use this identifier to cite or link to this item: https://doi.org/10.1158/0008-5472.CAN-06-1464
Title: Heparanase, hyaluronan, and CD44 in cancers: A breast carcinoma perspective
Authors: Götte, M.
Yip, G.W. 
Issue Date: 1-Nov-2006
Citation: Götte, M., Yip, G.W. (2006-11-01). Heparanase, hyaluronan, and CD44 in cancers: A breast carcinoma perspective. Cancer Research 66 (21) : 10233-10237. ScholarBank@NUS Repository. https://doi.org/10.1158/0008-5472.CAN-06-1464
Abstract: Glycosaminoglycans are major constituents of the cancer cell surface and the tumor stroma. The heparan sulfate degrading enzyme heparanase, hyaluronan, and its receptor CD44 are up-regulated in breast cancer, generating a microenvironment that promotes tumor progression and metastasis. Recent experimental and clinical evidence shows that heparanase, hyaluronan, and CD44 regulate cancer cell proliferation, migration, and invasion, as well as tumor-associated angiogenesis and are correlated with patient survival. These findings suggest that they may be used as prognostic factors and targets for breast cancer treatment. ©2006 American Association for Cancer Research.
Source Title: Cancer Research
URI: http://scholarbank.nus.edu.sg/handle/10635/120695
ISSN: 00085472
DOI: 10.1158/0008-5472.CAN-06-1464
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

245
checked on Jun 20, 2018

WEB OF SCIENCETM
Citations

227
checked on Jun 20, 2018

Page view(s)

42
checked on Jun 1, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.